A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis

Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable...

Descripción completa

Detalles Bibliográficos
Autores principales: Keum, Hyeongseop, Kim, Dohyeon, Kim, Jinjoo, Kim, Tae Woo, Whang, Chang-Hee, Jung, Wonsik, Jon, Sangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218594/
https://www.ncbi.nlm.nih.gov/pubmed/34175563
http://dx.doi.org/10.1016/j.biomaterials.2021.120986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218594/
https://www.ncbi.nlm.nih.gov/pubmed/34175563
http://dx.doi.org/10.1016/j.biomaterials.2021.120986

Ejemplares similares